A citation-based method for searching scientific literature

Elisabete Augusto, Frédéric Gambino. Front Mol Neurosci 2019
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity





Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons.
Corey Baimel, Benjamin K Lau, Min Qiao, Stephanie L Borgland. Cell Rep 2017
71
50

Dynorphins regulate fear memory: from mice to men.
Andras Bilkei-Gorzo, Susanne Erk, Britta Schürmann, Daniela Mauer, Kerstin Michel, Henning Boecker, Lukas Scheef, Henrik Walter, Andreas Zimmer. J Neurosci 2012
37
50

Direct inhibition of the N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393.
N G Castro, M C de Mello, F G de Mello, Y Aracava. Br J Pharmacol 1999
58
50

Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone.
Walter Wittmann, Eduard Schunk, Iris Rosskothen, Stefano Gaburro, Nicolas Singewald, Herbert Herzog, Christoph Schwarzer. Neuropsychopharmacology 2009
120
50



Kappa opioid receptors mediate where fear is expressed following extinction training.
Sindy Cole, Rick Richardson, Gavan P McNally. Learn Mem 2011
14
50

Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals.
Massimo Grilli, Elisa Neri, Stefania Zappettini, Francesca Massa, Angela Bisio, Giovanni Romussi, Mario Marchi, Anna Pittaluga. Neuropharmacology 2009
33
50

D(1) receptors in prefrontal cells and circuits.
P S Goldman-Rakic, E C Muly, G V Williams. Brain Res Brain Res Rev 2000
577
50

Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain.
A Mansour, H Khachaturian, M E Lewis, H Akil, S J Watson. J Neurosci 1987
865
50


Single-cell transcriptomic evidence for dense intracortical neuropeptide networks.
Stephen J Smith, Uygar Sümbül, Lucas T Graybuck, Forrest Collman, Sharmishtaa Seshamani, Rohan Gala, Olga Gliko, Leila Elabbady, Jeremy A Miller, Trygve E Bakken,[...]. Elife 2019
25
50

Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli.
Stephan Lammel, Daniela I Ion, Jochen Roeper, Robert C Malenka. Neuron 2011
451
50

Species differences in the concentrations and distributions of opioid binding sites.
L E Robson, M G Gillan, H W Kosterlitz. Eur J Pharmacol 1985
97
50

Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor.
Tao Che, Susruta Majumdar, Saheem A Zaidi, Pauline Ondachi, John D McCorvy, Sheng Wang, Philip D Mosier, Rajendra Uprety, Eyal Vardy, Brian E Krumm,[...]. Cell 2018
183
50


A microdialysis profile of dynorphin A(1-8) release in the rat nucleus accumbens following alcohol administration.
Peter W Marinelli, Minh Lam, Li Bai, Rémi Quirion, Christina Gianoulakis. Alcohol Clin Exp Res 2006
80
50


Diuretic effects, pharmacokinetics, and safety of a new centrally acting kappa-opioid agonist (CI-977) in humans.
P A Reece, A J Sedman, S Rose, D S Wright, R Dawkins, R Rajagopalan. J Clin Pharmacol 1994
60
50


Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex.
Guojun Chen, Paul Greengard, Zhen Yan. Proc Natl Acad Sci U S A 2004
158
50

Interneuron cell types are fit to function.
Adam Kepecs, Gordon Fishell. Nature 2014
559
50


Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism.
Nolan R Williams, Boris D Heifets, Christine Blasey, Keith Sudheimer, Jaspreet Pannu, Heather Pankow, Jessica Hawkins, Justin Birnbaum, David M Lyons, Carolyn I Rodriguez,[...]. Am J Psychiatry 2018
172
50


Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
Michael R Bruchas, Charles Chavkin. Psychopharmacology (Berl) 2010
190
50

Cloning and promoter mapping of mouse kappa opioid receptor gene.
H C Liu, S Lu, L B Augustin, R F Felsheim, H C Chen, H H Loh, L N Wei. Biochem Biophys Res Commun 1995
25
50

Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats.
Lisa E Baker, John J Panos, Bryan A Killinger, Mary M Peet, Lisa M Bell, Larissa A Haliw, Sheryl L Walker. Psychopharmacology (Berl) 2009
41
50

Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain.
Andrej Nikoshkov, Yasmin L Hurd, Tatiana Yakovleva, Igor Bazov, Zoya Marinova, Gvido Cebers, Natalia Pasikova, Anna Gharibyan, Lars Terenius, Georgy Bakalkin. FASEB J 2005
38
50

Efficacy and safety of a novel ĸ-agonist for managing intractable pruritus in dialysis patients.
Hiroo Kumagai, Toshiya Ebata, Kenji Takamori, Katsumasa Miyasato, Taro Muramatsu, Hidetomo Nakamoto, Masanao Kurihara, Tomoji Yanagita, Hiromichi Suzuki. Am J Nephrol 2012
87
50

Spine synapse remodeling in the pathophysiology and treatment of depression.
Catharine H Duman, Ronald S Duman. Neurosci Lett 2015
134
50

Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.
Jeffrey J Liu, Yi-Ting Chiu, Kelly M DiMattio, Chongguang Chen, Peng Huang, Taylor A Gentile, John W Muschamp, Alan Cowan, Matthias Mann, Lee-Yuan Liu-Chen. Neuropsychopharmacology 2019
47
50

Distribution of kappa opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study.
A M DePaoli, K M Hurley, K Yasada, T Reisine, G Bell. Mol Cell Neurosci 1994
72
50


Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.
Hugo A Tejeda, Danielle S Counotte, Eric Oh, Sammanda Ramamoorthy, Kristin N Schultz-Kuszak, Cristina M Bäckman, Vladmir Chefer, Patricio O'Donnell, Toni S Shippenberg. Neuropsychopharmacology 2013
74
50

Bidirectional modulation of anxiety-related and social behaviors by amygdala projections to the medial prefrontal cortex.
A C Felix-Ortiz, A Burgos-Robles, N D Bhagat, C A Leppla, K M Tye. Neuroscience 2016
170
50

Agonist-induced phosphorylation of the kappa-opioid receptor.
S M Appleyard, T A Patterson, W Jin, C Chavkin. J Neurochem 1997
52
50



Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers.
David Matuskey, Mark Dias, Mika Naganawa, Brian Pittman, Shannan Henry, Songye Li, Hong Gao, Jim Ropchan, Nabeel Nabulsi, Richard E Carson,[...]. Neuropsychopharmacology 2019
10
50

Active properties of neocortical pyramidal neuron dendrites.
Guy Major, Matthew E Larkum, Jackie Schiller. Annu Rev Neurosci 2013
197
50

Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain.
Shu Lin, Dana Boey, Nicola Lee, Christoph Schwarzer, Amanda Sainsbury, Herbert Herzog. Neuropeptides 2006
42
50

Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
William A Carlezon, Andrew D Krystal. Depress Anxiety 2016
72
50

Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: a positron emission tomography study using [¹⁸F]fallypride.
Johan Lataster, Dina Collip, Jenny Ceccarini, David Haas, Linda Booij, Jim van Os, Jens Pruessner, Koen Van Laere, Inez Myin-Germeys. Neuroimage 2011
70
50

κ-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites.
Maenghee Kang-Park, Brigitte L Kieffer, Amanda J Roberts, George R Siggins, Scott D Moore. J Pharmacol Exp Ther 2013
36
50

Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.
Kouichi Kimura, Ai Wakamatsu, Yutaka Suzuki, Toshio Ota, Tetsuo Nishikawa, Riu Yamashita, Jun-ichi Yamamoto, Mitsuo Sekine, Katsuki Tsuritani, Hiroyuki Wakaguri,[...]. Genome Res 2006
347
50

Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs.
Hugo A Tejeda, Ashley N Hanks, Liam Scott, Carlos Mejias-Aponte, Zoë A Hughes, Patricio O'Donnell. Neuropsychopharmacology 2015
29
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.